about
Pregnancy and vascular liver diseaseSecond infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapyGene expression and hepatitis C virus infectionFactor V Leiden related Budd-Chiari syndromeWilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamineReview article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.Design and optical characterization of a large continuous phase plate for Laser Integration Line and Laser Megajoule facilities.Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin.Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients.[Severe thrombopenia as single sign of hemophagocytosis in a patient with cirrhosis and lethal infection of ascitis fluid by Escherichia coli].Pregnancy and delivery in patients with portal vein cavernoma.Cancer awareness in atypical thrombotic microangiopathies.Hypercoagulability in cirrhosis: causes and consequences.Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis CDonor safety in living related liver transplantation: underestimation of the risks for deep vein thrombosis and pulmonary embolism.Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation.Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.Hepatic granulomas and hepatic sarcoidosis.Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.Hepatic veins as a site of clot formation following liver resection.Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosisCholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.Hepatic vein thrombosis (Budd-Chiari syndrome).Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liverSpectrum of portal vein thrombosis in the West.Budd-Chiari syndrome: a review by an expert panel.Changes in autophagic response in patients with chronic hepatitis C virus infection.Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseBehcet's disease in Budd-Chiari syndrome.Aetiological factors of Budd-Chiari syndrome in AlgeriaThe diagnosis and management of the Budd-Chiari syndrome: consensus and controversies.Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulationQuantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.Congenital hepatic fibrosis: CT findings in 18 adults.Multifactorial aetiology of hepatic infarction: a case report with literature review.Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.Impact of ribavirin dose on retreatment of chronic hepatitis C patients
P50
Q27025448-011C81C5-5D3E-4FEB-87FE-785B97C6A399Q27477965-50574F14-D6C4-4087-B25E-E07C61E497C7Q27488345-56E39F6B-C716-4EEA-9C35-CC6D9A24AFD1Q28345961-7144F3E3-42FC-4103-8A3E-1A55150C56CEQ28365364-8EE34DD4-B081-42B0-B469-3B800D7FEE59Q30244631-625F5E82-5CA2-4860-AEE2-95B7E8F5EB9FQ30926510-3EAF8EB5-3AEA-4E11-A5F0-851704CAAFD2Q33246213-8AA4A81C-77A0-4273-B24A-23C240B15B3BQ33367606-E28983A4-DD99-4CD6-A7F2-0D5263CF8BF0Q33378108-6F2877A8-60E8-453F-947B-51156A187A0AQ33385764-B48DB7AC-1EAD-4607-A060-10C222EB9F3FQ33385833-C8AC07E8-36E1-429A-BCBD-E014C7C51045Q33396091-CBC1221C-89C0-4205-A68F-D30EC14D23EAQ33425404-01245267-C385-4C16-9626-C32749777303Q33887760-CDFD1E09-EED0-4945-8372-8887FD509064Q33957581-461B9B00-E289-45AB-B502-6D98A78CDDD0Q33958028-3CC1197C-6A97-4E97-B42B-C89DF07DC3CBQ34001610-4126336A-E94A-4B6C-97E4-AFC568710409Q34046488-99FC3C28-5B8D-4FEA-8680-3FAD35529173Q34170418-7594DA5F-B27A-4BBE-B3AE-0A30FBA56166Q34295394-D1E7C6A5-5CC4-4069-B3CC-ABFAC859F23AQ34497513-829557F7-1AB0-4AEA-9A76-A8A0CB365E94Q34526007-52235AA9-089F-4904-9F71-2906F970D082Q34530886-E20E3855-C7E9-4AA8-8078-2FC57A56EA45Q34531090-56EE6FAB-062C-4C6E-A7B6-6AAEF17BFB8DQ34584402-EA153394-909B-45CF-8A76-6934693B0C67Q34760038-5711CE9C-F230-4ED9-A774-0749F21C27EEQ35020757-DD48954C-488D-48DE-8E9C-6CD93834FD2FQ35066120-DA079020-A07D-48E9-8766-ACE4364627F8Q35071429-FE319EA2-0D54-449C-A002-4EBCCFD3C40AQ35105799-D5BA41F3-A4B3-48EB-AF93-BBCEEF230D55Q35360101-1FEAA97D-D7ED-4C40-AF0F-B1A1D4DD955DQ35543971-5D207086-2A51-4BB6-B4BF-25F5E129EE9CQ35545011-0F885588-7854-456F-AE4F-F57A9F294338Q35597379-384A0227-E113-4CE1-A1EB-58991BC98C93Q35597990-4407E42C-17B0-4BC6-B4FA-D3BE3F8BAF1BQ35678281-AF939A8F-35E2-47A6-BE1C-BC45C9E33677Q35695335-4903C0FE-F0F8-4E27-BEF7-323FCDF627DBQ35761351-8CD8852D-865E-450D-9A4D-90519A39F835Q36049907-F4733C59-7148-4720-B5B5-BF82DA6C19B3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dominique C Valla
@ast
Dominique C Valla
@en
Dominique C Valla
@es
Dominique C Valla
@nl
Dominique C Valla
@sl
type
label
Dominique C Valla
@ast
Dominique C Valla
@en
Dominique C Valla
@es
Dominique C Valla
@nl
Dominique C Valla
@sl
prefLabel
Dominique C Valla
@ast
Dominique C Valla
@en
Dominique C Valla
@es
Dominique C Valla
@nl
Dominique C Valla
@sl
P214
P106
P213
0000 0000 0015 9071
P214
P31
P496
0000-0002-4460-7643
P735
P7859
viaf-76323825